Use of Consumer Sleep Technology to Treat Shift Work Disorder (SHIFT)

  • End date
    Jan 31, 2025
  • participants needed
  • sponsor
    Henry Ford Health System
Updated on 8 July 2022


The purpose of this study is to examine the effectiveness of a personalized light exposure schedule for Shift Work Disorder (SWD) in night shift workers compared to a non-personalized light exposure schedule.


Participants will be randomized into each condition (n = 25) in a 1:1 ratio. Variables of interest, dim light melatonin onset (DLMO) and shift work disorder (SWD) symptoms, will be assessed before and after the intervention, which will last two weeks. All participants (N=50) will be asked to wear an Apple Watch for two weeks leading up to an in-lab visit. Activity data collection from the Apple Watch will be processed through a mathematical model of the human circadian pacemaker (previously validated in SWD) to generate estimates of DLMO. This two-week period is followed by a 27-hour laboratory visit for pre-treatment assessment of DLMO (hourly saliva melatonin samples over 24 hours). At the end of this visit, participants will receive an orientation to the SHIFT mobile application, where they will be able to assess their prescribed light exposure schedule.

Condition Shift-work Disorder
Treatment Phototherapy
Clinical Study IdentifierNCT05186233
SponsorHenry Ford Health System
Last Modified on8 July 2022


Yes No Not Sure

Inclusion Criteria

Participants must work at least 2 night shifts a week
Participants must have night shifts starting between 18:00 and 02:00 and lasting 8 to 12 hours
Participants must have maintained this night shift schedule for at least 6 months
Participants must have Shift Work Disorder, diagnosed based on ICSD-3 criteria

Exclusion Criteria

Medical history of central nervous system disorders
Medical history of other sleep disorders
Diagnosis of an unstable major medical condition medical chart review
Dependence on alcohol (≥ 4 beverages a day)
Heavy tobacco use (≥ 10 cigarettes per day)
Recreational drug use
Use of medications impacting central nervous system functioning
Caffeine use in excess of 5-6 servings (~ 600mg) per day
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note